DrugDigest: Imatinib ( Gleevec ): Information on dosage, usage, side effects, interactions, and drug comparisons including generics when available.
Gleevec: Imatinib mesylate. Features prescribing and reimbursement information for US residents.
Gleevec Consumer Information - FDA: Patient FAQ in html format with a link to approved labeling in pdf format.
Gleevec Information: Features information from the FDA's Center for Drug Evaluation and Research including news releases, FAQs, approval letter, and draft package insert.
Gleevec Resource Center: Features articles, news releases, FAQs, and drug information.
Gleevec's Glory Days: Howard Hughes Medical Institute article, available in HTML and PDF format.
Imatinib ( Glivec ) - International Site: Manufacturer's information on this prescription medication used in the treatment of Chronic Myelogenous Leukemia (CML) and Gastrointestinal Stromal Tumors (GIST).
Imatinib Mesylate: Information from the RxList.
Life Raft Group: Features newsletters from this group of patients who are taking part in the Gleevec trials to treat gastrointestinal stromal tumors, a form of cancer.
Newcastle CML: Press release about the STI571 trials in the UK.
Novartis Pharmaceuticals Canada: Gleevec: Prescribing and patient information, from the manufacturer.
STI571 Digest: Reports, news releases, list of current drug trials, and articles from the NIH's National Cancer Institute.
Unofficial Gleevec Site: Features a history of the drug, interviews with medical professionals, message boards, FAQs, news, and an album of thank yous to Dr. Druker, Gleevec's primary researcher.
Yahoo! Groups: Gleevec: Discussion forum for anyone interested in Gleevec treatments.